社论:预防COVID-19症状性感染的灭活疫苗

Clinical eHealth Pub Date : 2023-05-03 DOI:10.1016/j.ceh.2023.04.001

Yifan Chen

{"title":"社论:预防COVID-19症状性感染的灭活疫苗","authors":"Yifan Chen","doi":"10.1016/j.ceh.2023.04.001","DOIUrl":null,"url":null,"abstract":"<div><p>Omicron variants of SARS-CoV-2 have been become the dominant variant family among more than 100 countries and regions around the world. There are still limited data on how inactivated COVID-19 vaccines prevent Omicron-related symptomatic infection, transmission, hospital admission, and death3. Recently, Dawei Yang et al. published a paper in the to explore the effect of inactivated COVID-19 vaccines on Omicron from the perspective of real-world observation data.</p></div>","PeriodicalId":100268,"journal":{"name":"Clinical eHealth","volume":"6 ","pages":"Pages 1-2"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Editorials: Inactivated vaccines protection against COVID-19 symptomatic infections\",\"authors\":\"Yifan Chen\",\"doi\":\"10.1016/j.ceh.2023.04.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Omicron variants of SARS-CoV-2 have been become the dominant variant family among more than 100 countries and regions around the world. There are still limited data on how inactivated COVID-19 vaccines prevent Omicron-related symptomatic infection, transmission, hospital admission, and death3. Recently, Dawei Yang et al. published a paper in the to explore the effect of inactivated COVID-19 vaccines on Omicron from the perspective of real-world observation data.</p></div>\",\"PeriodicalId\":100268,\"journal\":{\"name\":\"Clinical eHealth\",\"volume\":\"6 \",\"pages\":\"Pages 1-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical eHealth\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2588914123000072\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical eHealth","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2588914123000072","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

严重急性呼吸系统综合征冠状病毒2型的奥密克戎变异株已成为全球100多个国家和地区的主要变异株家族。关于新冠肺炎灭活疫苗如何预防奥密克戎相关症状感染、传播、住院和死亡的数据仍然有限3。近日，杨大伟等在《》杂志上发表论文，从真实世界的观察数据出发，探讨新冠肺炎灭活疫苗对奥密克戎的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Editorials: Inactivated vaccines protection against COVID-19 symptomatic infections

Omicron variants of SARS-CoV-2 have been become the dominant variant family among more than 100 countries and regions around the world. There are still limited data on how inactivated COVID-19 vaccines prevent Omicron-related symptomatic infection, transmission, hospital admission, and death3. Recently, Dawei Yang et al. published a paper in the to explore the effect of inactivated COVID-19 vaccines on Omicron from the perspective of real-world observation data.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical eHealth

CiteScore

8.10

自引率

0.00%

发文量